SBC Medical Group (SBC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    SBC Medical Group

    NASDAQ: SBC · Real-Time Price · USD
    4.46
    -0.27 (-5.71%)
    At close: Sep 10, 2025, 3:59 PM
    4.37
    -2.02%
    After-hours: Sep 10, 2025, 07:59 PM EDT

    SBC Medical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 205.42M 193.54M 174.16M
    Cost of Revenue
    		 49.37M 56.24M 59.33M
    Gross Profit
    		 156.05M 137.3M 114.83M
    Operating Income
    		 70.3M 70.66M 20.12M
    Interest Income
    		 19.94K 86.75K 472.38K
    Pretax Income
    		 73.46M 73.58M 23.68M
    Net Income
    		 46.61M 39.37M 6.32M
    Selling & General & Admin
    		 70.09M 66.23M 93.48M
    Research & Development
    		 n/a n/a n/a
    Other Expenses
    		 15.66M 409.03K 1.23M
    Operating Expenses
    		 85.75M 66.64M 94.72M
    Interest Expense
    		 28.3K 45.29K 31.44K
    Selling & Marketing Expenses
    		 2.78M n/a n/a
    Cost & Expenses
    		 135.11M 122.88M 154.04M
    Income Tax Expense
    		 26.77M 35.02M 18.12M
    Shares Outstanding (Basic)
    		 96.56M 100.74M 100.74M
    Shares Outstanding (Diluted)
    		 96.56M 100.74M 100.74M
    EPS (Basic)
    		 0.48 0.39 0.06
    EPS (Diluted)
    		 0.48 0.39 0.06
    EBITDA
    		 77.28M 85.87M 29.64M
    EBIT
    		 73.48M 73.62M 23.71M
    Depreciation & Amortization
    		 3.8M 12.25M 5.93M

    Add to Watchlist